The role of active herpesvirus infection in the formation of atopic dermatitis and psoriasis

The results of previous studies suggest the involvement of herpes viruses in the development of atopic dermatitis and psoriasis, but there is no convincing evidence. Aim of the study was to evaluate the role of active herpesvirus infection in exacerbation of atopic dermatitis and psoriasis. Material and methods. The analysis of the incidence of infectious mononucleosis, genital herpes, cytomegalovirus infection, skin and subcutaneous tissue diseases, atopic dermatitis, psoriasis in Russia in 2000–2020 was carried out. 92 blood donors and 97 patients with skin and subcutaneous tissue diseases (44 with atopic dermatitis and 53 with psoriasis) were examined for the presence of immunoglobulins M and G to herpes simplex viruses (HSV1,2), Epstein-Barr (EBV), cytomegalovirus (CMV), human herpes type 6 (HНV6). Results and discussion. A significant strong direct correlation was revealed between the incidence of genital herpes and diseases of the skin and subcutaneous tissue (p = 0.85), atopic dermatitis (p = 0.85); infectious mononucleosis and psoriasis (p = 0.85). The frequency of detection of IgM to HSV1,2, in total, IgG EA and IgM VCA EBV in the group of patients is significantly higher than in donors (p < 0.05). In patients with atopic dermatitis, IgM to HSV1 were detected significantly more often than in individuals with psoriasis, and markers of active EBV infection were significantly less common. The presence of IgM HSV-1 statistically significantly increases the incidence of atopic dermatitis (relative risk (RR) = 2.3, 95 % confidence interval (95 % CI) 1.6–3.3)), IgM VCA and IgG EA EBV – the incidence of psoriasis (RR = 2.3, 95 % CI 1.5–3.3). Conclusions. It has been shown for the first time that active HSV1,2 infection is a trigger factor for the development of atopic dermatitis, EBV infection is psoriasis.

1. Xu R., Zhou Y., Cai L., Wang L., Han J., Yang X., Chen J., Chen J., Ma C., Shen L. Co-reactivation of the human herpesvirus alpha subfamily (virus-1 and varicella zoster virus) in a critically ill patient with COVID-19. Br. J. Dermatol. 2020;183(6):1145–1147. doi: 10.1111/bjd.19484

2. Solomay T.V., Semenenko T.A., Karazhas N.V., Rybalkina T.N., Veselovskij P.A., Pul’nova N.L., Gotvjanskaja T.P., Golosova S.A., Ivanova I.V., Bosh’jan R.E., Kulakov D.Ju. Features of changes in the indicators of the immune status of persons with active and latent forms of herpesvirus infections. Permskiy meditsinskiy zhurnal = Perm Medical Journal. 2021;38(1):46–63. [In Russian]. doi: 10.17816/pmj38146 %63

3. Solomay T.V., Semenenko T.A., Filatov N.N., Khabazov R.I., Dupik N.V., Dundua D.P., Kolyshkina N.A., Konev A.V. Risk of circulatory diseases on the example of heart rhythm disorders in patients with serological markers of Epstein–Barr infection. Analiz riska zdorov’yu = Health Risk Analysis. 2021;(3):150–159. [In Russian]. doi: 10.21668/health.risk/2021.3.15

4. Solomay T.V., Semenenko T.A., Karazhas N.V., Rybalkina T.N., Kornienko M.N., Bosh’jan R.E., Golosova S.A., Ivanova I.V. Assessing risks of infection with herpes viruses during transfusion of donor blood and its components. Analiz riska zdorov’yu = Health Risk Analysis. 2020;(2):136–142. [In Russian]. doi: 10.21668/health.risk/2020.2.15.eng

5. Hafez S.F., Shehata I.H., Abdel Aziz G.A., Kamal M.M. Active cytomegalovirus infection in patients with atopic dermatitis. Egypt. J. Immunol. 2005;12(2):1–12.

6. Miyagawa F., Asada H. Current perspective regarding the immunopathogenesis of drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS). Int. J. Mol. Sci. 2021;22(4):2147. doi: 10.3390/ijms22042147

7. di Lernia V., Mansouri Y. Epstein–Barr virus and skin manifestations in childhood. Int. J. Dermatol. 2013;52(10):1177–1184. doi: 10.1111/j.13654632.2012.05855.x

8. Lu J.W., Lu Y. The role Epstein–Barr virus played in the outcome of skin diseases. Zhonghua Yi XueZaZhi. 2021;101(20):1458–1462. [In Chinese]. doi: 10.3760/cma.j.cn112137-20201119-03144

9. Jamiyan T., Nakazato Y., Kuroda H., Kojima M., Imai Y. Сharacteristic histological findings of asymptomatic EBV-associated lymphoproliferative disorders in tonsils. J. Clin. Exp. Hematop. 2018;58(3):122–127. doi: 10.3960/jslrt.18017

10. Kaplan F., Topal E. Acute generalized exanthematouspustulosis due to Epstein–Barr virus infection in a neonate. Pediatr. Dermatol. 2021;38(5):1354– 1356. doi: 10.1111/pde.14684

11. Teng Y., Xie W., Tao X., Liu N., Yu Y., Huang Y., Xu D., Fan Y. Infection-provoked psoriasis: Induced or aggravated (Review). Exp. Ther. Med. 2021;21(6):567. doi: 10.3892/etm.2021.9999

12. Beljaeva L.M., Mikul’chik N.V. Modern approaches to therapy and prevention of atopic dermatitis in children. Meditsinskie novosti = Medical News. 2020;(6):37–42 [In Russian].

13. Traidl S., Roesner L., Zeitvogel J., Werfel T. Eczema herpeticum in atopic dermatitis. Allergy. 2021;76(10):3017–3027. doi: 10.1111/all.14853

14. Damour A., Garcia M., Seneschal J., Lévêque N., Bodet C. Eczema herpeticum: clinical and pathophysiological aspects. Clin. Rev. Allergy Immunol. 2020;59(1):1–18. doi: 10.1007/s12016-019-08768-3

15. Cabanillas B., Weighardt H., Izquierdo E., Förster I., Novak N. IgE reactivity against virus 1 in patients with atopic dermatitis complicated by eczema herpeticum. Allergy. 2020;75(1):226–229. doi: 10.1111/all.13986

16. Solomay T.V., Semenenko T.A., Filatov N.N., Kolbutova K.B., Olejnikova D.Ju., Karazhas N.V. The role of children and adults as a reservoir of pathogens during the seasonal rise in the incidence of upper respiratory tract infections. Detskie infektsii = Children Infections. 2020;19(3):5–11. [In Russian]. doi.org/10.22627/2072-8107-2020-19-3-5-11

17. Gudjonsson J.E., Thorarinsson A.M., Sigurgeirsson B., Kristinsson K.G., Valdimarsson H. Streptococcal throat infections and exacerbation of chronic plaque psoriasis: A prospective study. Br. J. Dermatol. 2003;149:530–534. doi: 10.1046/j.13652133.2003.05552.x

18. Thorleifsdottir R.H., Sigurdardottir S.L., Sigurgeirsson B., Olafsson J.H., Sigurdsson M.I., Petersen H., Gudjonsson J.E., Johnston A., Valdimarsson H. Patient-reported outcomes and clinical response in patients with moderate-to-severe plaque psoriasis treated with tonsillectomy: A randomized controlled trial. Acta Derm. Venereol. 2016;97:340–345. doi: 10.2340/00015555-2562

19. Jiyad Z., Moriarty B., Creamer D., Higgins E. Generalized pustular psoriasis associated with Epstein– Barr virus. Clin. Exp. Dermatol. 2015;40(2):146–148. doi: 10.1111/ced.12493

20. Loh E., Fung M.A., Maverakis E. Acute Guttate psoriasis in a 15-year-old girl with Epstein–Barr virus infection. Arch. Dermatol. 2012;148:658–659. doi: 10.1001/archdermatol.2011.3517

21. Ali F.R., Green R., McMullen E., Motta L., Judge M.R. Cutaneous cytomegalovirus complicating pustular psoriasis. Br. J. Dermatol. 2014;71:670–671. doi: 10.1111/bjd.13026

22. Zampetti A., Gnarra M., Linder D., Digiuseppe M.D., Carrino N., Feliciani C: Psoriatic pseudobalanitis circinata as a post-viral koebner phenomenon. Case Rep. Dermatol. 2010;2:183–188. doi: 10.1159/000321012

23. Kurosawa S., Sekiya N., Fukushima K., Ikeuchi K., Fukuda A., Takahashi H., Chen F., Hasegawa H., Katano H., Hishima T., Setoguchi K. Unusual manifestation of disseminated herpessimplexvirus type 2 infection associated with pharyngotonsilitis, esophagitis, and hemophagocyticlymphohisitocytosis without genital involvement. BMC Infect. Dis. 2019;19(1):65. doi: 10.1186/s12879-019-3721-0

24. Xu R., Zhou Y., Cai L., Wang L., Han J., Yang X., Chen J., Chen J., Ma C., Shen L. Co-reactivation of the human herpesvirus alpha subfamily (herpes simplex virus-1 and varicella zoster virus) in a critically ill patient with COVID-19. Br. J. Dermatol. 2020;183(6):1145–1147. doi: 10.1111/bjd.19484

25. Solomay T.V., Semenenko T.A., Isaeva E.I., Vetrova E.N., Chernyshova A.I., Romenskaja Je.V., Karazhas N.V. COVID-19 and the risk of herpesvirus reactivation. Epidemiologiya i infektsionnye bolezni. Aktual’nye voprosy = Epidemiology and Infectious Diseases. Current Items. 2021;11(2):55–62. [In Russian]. doi: 10.18565/epidem.2021.11.2.55–62

26. Novak N., Weighardt H., Valdelvira R., Izquierdo E., Förster I., Cabanillas B. Herpessimplex virus 1 proteins can induce skin inflammation in an atopicdermatitis-like mouse model. Exp. Dermatol. 2021;30(11):1699–1704. doi: 10.1111/exd.14327

27. Neimann A.L., Hodinka R.L., Joshi Y.B., Elkan M., van Voorhees A.S., Gelfand J.M. Epstein–Barr virus and human herpesvirus type 6 infection in patients with psoriasis. Eur. J. Dermatol. 2006;16:548–552.

28. Jons D., Persson Berg L., Sundström P., Haghighi S., Axelsson M., Thulin M., Bergström T., Andersen O. Follow-up after infectious mononucleosis in search of serological similarities with presymptomatic multiple sclerosis. Mult. Scler. Relat. Disord. 2021;56:103288. doi: 10.1016/j.msard.2021.103288

29. Deeba E., Koptides D., Gaglia E., Constantinou A., Lambrianides A., Pantzaris M., Krashias G., Christodoulou C. Evaluation of Epstein–Barr virus-specific antibodies in Cypriot multiple sclerosis patients. Mol. Immunol. 2019;105:270–275. doi: 10.1016/j. molimm.2018.12.010

30. De Paschale M., Clerici P. Serological diagnosis of Epstein–Barr virus infection: Problems and solutions. World J. Virol. 2012;1(1):31–43. doi: 10.5501/ wjv.v1.i1.31